AGL 38.31 Decreased By ▼ -0.25 (-0.65%)
AIRLINK 213.80 Increased By ▲ 6.03 (2.9%)
BOP 10.05 Decreased By ▼ -0.01 (-0.1%)
CNERGY 6.75 Decreased By ▼ -0.33 (-4.66%)
DCL 9.85 Decreased By ▼ -0.14 (-1.4%)
DFML 40.89 Decreased By ▼ -0.25 (-0.61%)
DGKC 102.30 Decreased By ▼ -1.16 (-1.12%)
FCCL 36.39 Increased By ▲ 0.04 (0.11%)
FFBL 91.00 Decreased By ▼ -0.59 (-0.64%)
FFL 14.10 Decreased By ▼ -0.50 (-3.42%)
HUBC 136.50 Decreased By ▼ -2.93 (-2.1%)
HUMNL 14.00 Decreased By ▼ -0.10 (-0.71%)
KEL 5.86 Decreased By ▼ -0.11 (-1.84%)
KOSM 7.33 Decreased By ▼ -0.53 (-6.74%)
MLCF 46.98 Decreased By ▼ -0.30 (-0.63%)
NBP 66.38 Decreased By ▼ -7.38 (-10.01%)
OGDC 221.00 Decreased By ▼ -1.66 (-0.75%)
PAEL 38.00 Decreased By ▼ -0.11 (-0.29%)
PIBTL 9.02 Decreased By ▼ -0.25 (-2.7%)
PPL 204.00 Decreased By ▼ -1.85 (-0.9%)
PRL 39.50 Decreased By ▼ -0.35 (-0.88%)
PTC 26.20 Decreased By ▼ -0.42 (-1.58%)
SEARL 107.50 Decreased By ▼ -2.74 (-2.49%)
TELE 9.13 Decreased By ▼ -0.10 (-1.08%)
TOMCL 37.91 Decreased By ▼ -0.30 (-0.79%)
TPLP 13.74 Decreased By ▼ -0.03 (-0.22%)
TREET 26.00 Decreased By ▼ -0.45 (-1.7%)
TRG 59.60 Decreased By ▼ -0.94 (-1.55%)
UNITY 33.50 Decreased By ▼ -0.64 (-1.87%)
WTL 1.77 Decreased By ▼ -0.11 (-5.85%)
BR100 12,165 Decreased By -133.6 (-1.09%)
BR30 38,276 Decreased By -601.6 (-1.55%)
KSE100 113,411 Decreased By -1449.7 (-1.26%)
KSE30 35,724 Decreased By -472.5 (-1.31%)
World

Sweden to resume AstraZeneca jabs for over 65s

  • The vaccine is of great use for the elderly, among whom many fall seriously ill each day.
  • "At the same time, we haven't seen these rare and serious side effects among our elderly. That is the background to why we are lifting the suspension for people older than 65."
Published March 25, 2021

STOCKHOLM: Sweden will resume use of AstraZeneca's COVID-19 vaccine for people aged 65 and older, the health agency said on Thursday, but keep the pause in place for younger Swedes as it continues to investigate a potential link between the shots and rare cases of blood clots.

"The vaccine is of great use for the elderly, among whom many fall seriously ill each day," Director General Johan Carlson said in a statement on the agency's new guidelines to the regional authorities administering the vaccinations in Sweden.

"At the same time, we haven't seen these rare and serious side effects among our elderly. That is the background to why we are lifting the suspension for people older than 65."

Most countries which temporarily suspended the vaccine have now resumed administering shots following recommendations from the European Union's drug watchdog and the World Health Organization (WHO).

Both the European Medicines Agency (EMA) and the WHO said last week that the benefits of AstraZeneca's vaccine outweighed the risks.

Reuters

Comments

Comments are closed.